Mir Ali, a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California
For me, already settled on the shot and a long way down that road, the case for switching is weak
While semaglutide activates only the GLP-1 receptor, tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Iron supplements: These are notorious GI irritants that cause nausea, constipation, and can worsen heartburn
In weight management studies: Clinical trials showed the incidence of diarrhea ranging from 12% to 22% of participants, depending on the dosage
For men without obesity, the overall risk of ED with semaglutide is low (1.5%)